In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning.
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing new treatment options for kidney cancer, muscle-invasive bladder cancer, and metastatic castration-sensitive prostate cancer.
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing new treatments for prostate, bladder, and kidney cancers.
In the latest podcast from the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing potential new treatments for prostate cancer, germ cell tumors, and kidney cancer.
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing potential new treatments for prostate, bladder, and kidney cancers.
In this Clinical Trials in Genitourinary Cancers series podcast, experts discuss 3 clinical trials aiming to identify new treatments for prostate, bladder, and kidney cancers.
In the first podcast of the Clinical Trials in Genitourinary Cancers series, experts discuss 3 clinical trials that are currently exploring new ways of treating kidney, bladder, and prostate cancers.
